Loading [MathJax]/jax/output/SVG/jax.js
Research article

Epidemiology of cancer in Saudi Arabia thru 2010–2019: a systematic review with constrained meta-analysis

Running title: epidemiology of cancer in Saudi Arabia thru 2010–2019
  • Background: Cancer is emerging as a major global health-care system challenge with a growing burden worldwide. Due to the inconsistent cancer registry system in Saudi Arabia, the epidemiology of cancer is still dispersed in the country. Consequently, this review aimed to assemble the epidemiological metrics of cancer in Saudi Arabia in light of the available published data during the period from (2010–2019). Methods: Published literature from Saudi Arabia relating to cancer incidence, prevalence, risk factors, and other epidemiological metrics were accessed through electronic search in Medline/PubMed, Cochrane, Scopus, Web of Knowledge, Google Scholar, and public database that meet the inclusion criteria. Relevant keywords were used during the electronic search about different types of cancers in Saudi Arabia. No filters were used during the electronic searches. Data were pooled and odds ratios (ORs) and 95% confidence interval (95%CI) were calculated. A random-effects meta-analysis was performed to assess the well-determined risk factors associated with different types of cancers. Results: The most common cancers in Saudi Arabia are breast, colorectal, prostate, brain, lymphoma, kidney and thyroid outnumbering respectively. Their prevalence rates and OR (95%CI) as follow: breast cancer 53% and 0.93 (0.84–1.00); colon-rectal cancer (CRC) 50.9% and 1.2 (0.81–1.77); prostate cancer 42.6% and 3.2 (0.88–31.11); brain/Central Nervous System cancer 9.6% and 2.3 (0.01–4.2); Hodgkin and non-Hodgkin’s lymphoma 9.2% and 3.02 (1.48–6.17); kidney cancer 4.6% and 2.05 (1.61–2.61), and thyroid cancer 12.9% and 6.77 (2.34–19.53). Conclusion: Within the diverse cancers reported from Saudi Arabia, the epidemiology of some cancers magnitude 3-fold in the latest years. This increase might be attributed to the changing in the Saudi population lifestyle (adopting western model), lack of cancer awareness, lack of screening & early detection programs, social barriers toward cancer investigations. Obesity, genetics, sedentary lifestyle, tobacco use, viral infection, and iodine & Vit-D deficiency represent the apparent cancer risk factors in Saudi Arabia.

    Citation: Wedad Saeed Alqahtani, Nawaf Abdulrahman Almufareh, Dalia Mostafa Domiaty, Gadah Albasher, Manal Abduallah Alduwish, Huda Alkhalaf, Bader Almuzzaini, Salma Sanhaat AL-marshidy, Rgya Alfraihi, Abdelbaset Mohamed Elasbali, Hussain Gadelkarim Ahmed, Bassam Ahmed Almutlaq. Epidemiology of cancer in Saudi Arabia thru 2010–2019: a systematic review with constrained meta-analysis[J]. AIMS Public Health, 2020, 7(3): 679-696. doi: 10.3934/publichealth.2020053

    Related Papers:

    [1] Qiang Hou, Haiyan Qin . Global dynamics of a multi-stage brucellosis model with distributed delays and indirect transmission. Mathematical Biosciences and Engineering, 2019, 16(4): 3111-3129. doi: 10.3934/mbe.2019154
    [2] Yaoyao Qin, Xin Pei, Mingtao Li, Yuzhen Chai . Transmission dynamics of brucellosis with patch model: Shanxi and Hebei Provinces as cases. Mathematical Biosciences and Engineering, 2022, 19(6): 6396-6414. doi: 10.3934/mbe.2022300
    [3] Linhua Zhou, Meng Fan, Qiang Hou, Zhen Jin, Xiangdong Sun . Transmission dynamics and optimal control of brucellosis in Inner Mongolia of China. Mathematical Biosciences and Engineering, 2018, 15(2): 543-567. doi: 10.3934/mbe.2018025
    [4] Mingtao Li, Guiquan Sun, Juan Zhang, Zhen Jin, Xiangdong Sun, Youming Wang, Baoxu Huang, Yaohui Zheng . Transmission dynamics and control for a brucellosis model in Hinggan League of Inner Mongolia, China. Mathematical Biosciences and Engineering, 2014, 11(5): 1115-1137. doi: 10.3934/mbe.2014.11.1115
    [5] Yongbing Nie, Xiangdong Sun, Hongping Hu, Qiang Hou . Bifurcation analysis of a sheep brucellosis model with testing and saturated culling rate. Mathematical Biosciences and Engineering, 2023, 20(1): 1519-1537. doi: 10.3934/mbe.2023069
    [6] Zongmin Yue, Yuanhua Mu, Kekui Yu . Dynamic analysis of sheep Brucellosis model with environmental infection pathways. Mathematical Biosciences and Engineering, 2023, 20(7): 11688-11712. doi: 10.3934/mbe.2023520
    [7] Yicang Zhou, Zhien Ma . Global stability of a class of discrete age-structured SIS models with immigration. Mathematical Biosciences and Engineering, 2009, 6(2): 409-425. doi: 10.3934/mbe.2009.6.409
    [8] Kai Wang, Zhidong Teng, Xueliang Zhang . Dynamical behaviors of an Echinococcosis epidemic model with distributed delays. Mathematical Biosciences and Engineering, 2017, 14(5&6): 1425-1445. doi: 10.3934/mbe.2017074
    [9] Hongbin Guo, Michael Yi Li . Global dynamics of a staged progression model for infectious diseases. Mathematical Biosciences and Engineering, 2006, 3(3): 513-525. doi: 10.3934/mbe.2006.3.513
    [10] Cruz Vargas-De-León, Alberto d'Onofrio . Global stability of infectious disease models with contact rate as a function of prevalence index. Mathematical Biosciences and Engineering, 2017, 14(4): 1019-1033. doi: 10.3934/mbe.2017053
  • Background: Cancer is emerging as a major global health-care system challenge with a growing burden worldwide. Due to the inconsistent cancer registry system in Saudi Arabia, the epidemiology of cancer is still dispersed in the country. Consequently, this review aimed to assemble the epidemiological metrics of cancer in Saudi Arabia in light of the available published data during the period from (2010–2019). Methods: Published literature from Saudi Arabia relating to cancer incidence, prevalence, risk factors, and other epidemiological metrics were accessed through electronic search in Medline/PubMed, Cochrane, Scopus, Web of Knowledge, Google Scholar, and public database that meet the inclusion criteria. Relevant keywords were used during the electronic search about different types of cancers in Saudi Arabia. No filters were used during the electronic searches. Data were pooled and odds ratios (ORs) and 95% confidence interval (95%CI) were calculated. A random-effects meta-analysis was performed to assess the well-determined risk factors associated with different types of cancers. Results: The most common cancers in Saudi Arabia are breast, colorectal, prostate, brain, lymphoma, kidney and thyroid outnumbering respectively. Their prevalence rates and OR (95%CI) as follow: breast cancer 53% and 0.93 (0.84–1.00); colon-rectal cancer (CRC) 50.9% and 1.2 (0.81–1.77); prostate cancer 42.6% and 3.2 (0.88–31.11); brain/Central Nervous System cancer 9.6% and 2.3 (0.01–4.2); Hodgkin and non-Hodgkin’s lymphoma 9.2% and 3.02 (1.48–6.17); kidney cancer 4.6% and 2.05 (1.61–2.61), and thyroid cancer 12.9% and 6.77 (2.34–19.53). Conclusion: Within the diverse cancers reported from Saudi Arabia, the epidemiology of some cancers magnitude 3-fold in the latest years. This increase might be attributed to the changing in the Saudi population lifestyle (adopting western model), lack of cancer awareness, lack of screening & early detection programs, social barriers toward cancer investigations. Obesity, genetics, sedentary lifestyle, tobacco use, viral infection, and iodine & Vit-D deficiency represent the apparent cancer risk factors in Saudi Arabia.


    Brucellosis is an infectious bacterial disease often spread via direct contact with infected animals or contaminated animal products [1,2]. Brucellosis can transmit to other animals through direct contacts with infected animals or indirect transmission by brucella in the environment. The disease primarily affects cattle, sheep and dogs. In the real world, the infected sheep remain the main source of brucellosis infection, and the basic ewes and other sheep (which includes stock ram and fattening sheep) are often mixed feeding together, therefore there must exist the mixed cross infection between other sheep and basic ewes [3]. Brucellosis is prevalent for more than a century in many parts of the world, and it is well controlled in most developed countries. However, more than 500,000 new cases are reported each year around the world [4,5,6,7].

    Mathematical modeling has the potential to analyze the mechanisms of transmission and the complexity of epidemiological characteristics of infectious diseases [8]. In recent years, several mathematical modeling studies have reported on the transmission of brucellosis [3,9,10,11,12,13,14,15,16,17,18,19]. However, these earlier models have mainly focused on the spread of brucellosis between sheep and human through using the dynamic model. Only Li et al [3] proposed a deterministic multi-group model to study the brucellosis transmission among sheep (which the flock of sheep were divided into basic ewes and other sheep). However, they only gave the global stability of disease-free equilibrium and the existence the endemic equilibrium, but the uniqueness and global stability of the endemic equilibrium were not shown when the basic reproduction number is larger than 1. Multi-group model is a class of highly heterogenous models with complex interactions among distinct groups, and the difficulty of global dynamics of multi-group models lies in establishing uniqueness and global stability of endemic equilibrium when basic reproduction number is larger than one [20]. In this paper, we want to study the global dynamic behavior of multi-group type model for the transmission of brucellosis among sheep which are absent from previous papers [3]. We prove the uniqueness of positive endemic equilibrium through using proof by contradiction, and the global stability of endemic equilibrium by using Lyapunov function. Especially, we give the specific coefficients of global Lyapunov function, and show the calculation method of these specific coefficients. By running numerical simulations for the cases with the basic reproduction number to demonstrate the global stability of the equilibria and the unique endemic equilibrium, respectively. By some sensitivity analysis of the basic reproduction number on parameters, we find that vaccination rate of sheep and seropositive detection rate of recessive infected sheep are very important factor for brucellosis.

    This paper is organized as follows. In Section 2, we present the dynamical model. And the mathematical analysis including the uniqueness and global stability of positive endemic equilibrium will be given in Section 3. In Section 4, some numerical simulations are given on the global stability of the equilibria and the unique endemic equilibrium. Section 5 gives a discussion about main results.

    In previous paper [3], we proposed a multi-group model with cross infection between sheep and human. In this model, So(t),Eo(t),Io(t),Vo(t) and Sf(t),Ef(t),If(t),Vf(t) represent susceptible, recessive infected, quarantined seropositive infected, vaccinated other sheep and basic ewes, respectively. W(t) denotes the quantity of sheep brucella in the environment. Sh(t),Ih(t),Yh(t) represent susceptible individuals, acute infections, chronic infections, respectively. There are some assumptions on the dynamical transmission of brucellosis among sheep and from sheep to humans, which are demonstrated in the flowchart (See Figure 1). The following ordinary differential equations can describe a multi-group brucellosis model with Figure 1:

    {dSodt=Ao(βooEo+βofEf+βoW)So+λoVo(γo+do)So,dEodt=(βooEo+βofEf+βoW)So(co+do)Eo,dIodt=coEo(αo+do)Io,dVodt=γoSo(λo+do)Vo,dSfdt=Af(βffEf+βfoEo+βfW)Sf+λfVf(γf+df)Sf,dEfdt=(βffEf+βfoEo+βfW)Sf(cf+df)Ef,dIfdt=cfEf(αf+df)If,dVfdt=γfSf(λf+df)Vf,dWdt=ko(Eo+Io)+kf(Ef+If)(δ+nτ)W,dShdt=Ah(βhoEo+βhfEf+βhW)ShdhSh+pIh,dIhdt=(βhoEo+βhfEf+βhW)Sh(m+dh+p)Ih,dYhdt=mIhdhYh. (2.1)
    Figure 1.  Transmission diagram, where g(So)=(βooEo+βofEf+βoW)So, g(Sf)=(βffEf+βfoEo+βfW)Sf and g(Sh)=(βhoEo+βhfEf+βhW)Sh, respectively [3].

    Because the last three equations are independent of the first nine equations, we can only consider the first nine equations. Rewrite system (2.1) for general form into the following model:

    {dSidt=Ai(di+γi)Si+λiVi2j=1βijSiEjβiSiW,dEidt=2j=1βijSiEj+βiSiW(di+ci)Ei,dIidt=ciEi(di+αi)Ii,dVidt=γiSi(λi+di)Vi,dWdt=2i=1ki(Ei+Ii)δW.i=1,2. (2.2)

    Adding the first four equations of (2.2) gives

    d(Si+Ei+Ii+Vi)dtAidi(Si+Ei+Ii+Vi),

    which implies that limtsup(Si+Ei+Ii+Vi)Aidi. It follows from the last equation of (2.2) that limtsupW2i=1kiAidiδ. Hence, the feasible region

    X={(S1,E1,I1,V1,S2,E2,I2,V2,W)|0Si+Ei+Ii+ViAidi,0W2i=1kiAidiδ,i=1,2.}

    is positively invariant with respect to model (2.2). Model (2.2) always admits the disease-free equilibrium P0=(S0i,0,0,V0i,0)i=1,2 in X, where S0i=Ai(λi+di)di(di+λi+γi),V0i=Aiγidi(di+λi+γi), and P0 is the unique equilibrium that lies on the boundary of X.

    According to the definition of Rc in [21,22,23] and the calculation of Ro in our previous paper [3], we can obtain the basic reproduction number of model (2.2) is

    R0=ρ(FV1)=A11+A22+(A11A22)2+4A12A212,

    where

    A11=S01d1+c1(β11+β1k1(d1+α1+c1)δ(d1+α1)),A12=S01d2+c2(β12+β1k2(d2+α2+c2)δ(d2+α2)),
    A21=S02d1+c1(β21+β2k1(d1+α1+c1)δ(d1+α1)),A22=S02d2+c2(β22+β2k2(d2+α2+c2)δ(d2+α2)),
    S01=A1(d1+λ1)d1(d1+λ1+γ1),S02=A2(λ2+d2)d2(λ2+d2+γ2).

    In our previous paper [3], for the global stability of disease-free equilibrium and the existence of the positive endemic equilibrium of system (2.2), we have following theorems.

    Theorem 3.1. If R01, the disease-free equilibrium P0 of system (2.2) is globally asymptotically stable in the region X.

    Theorem 3.2. If R0>1, then system (2.2) admits at least one (componentwise) positive equilibrium, and there is a positive constant ϵ such that every solution (Si(t),Ei(t),Ii(t),W(t)) of system (2.2) with (Si(0),Ei(0),Ii(0),W(0))Rn+× Int R2n+1+ satisfies

    min{lim inftEi(t),lim inftIi(t),lim inftW(t)}ϵ,i=1,2,...,n.

    If R0>1, then it follows from Theorem 3.2 that system (2.2) is uniformly persistent, together with the uniform boundedness of solutions of (2.2) in the interior of X, which implies that (2.2) admits at least one endemic equilibrium in the interior of X.

    Let P=(Si,Ei,Ii,Vi,W),i=1,2 be a positive equilibrium of system (2.2), we will show its uniqueness in the interior of the feasible region X.

    Theorem 3.3. System (2.2) only exists a unique positive endemic equilibrium in the region X when R0>1.

    Proof. For the positive equilibrium P of system (2.2), we have the following equations:

    {Ai(di+γi)Si+λiVi2j=1βijSiEjβiSiW=0,2j=1βijSiEj+βiSiW(di+ci)Ei=0,ciEi(di+αi)Ii=0,γiSi(λi+di)Vi=0,2i=1ki(Ei+Ii)δW=0.i=1,2.

    It is easy to obtain that

    Vi=γiSidi+λi,di(Si+Vi)=Ai(di+ci)Ei,Ii=cidi+αiEi,W=2i=1ki(ci+di+αi)di+αiEiδ,
    Si2j=1βijEj+βiSi2i=1ki(ci+di+αi)di+αiEiδ=(di+ci)Ei,i=1,2.

    Hence, the positive equilibrium of system (2.2) is equivalent to the following system

    Mi(AiniEi)2j=1ξijEjniEi=0,i=1,2. (3.1)

    where

    Mi=di+λidi(di+λi+γi),ξij=βij+βikj(cj+dj+αj)δ(dj+αj),ni=di+ci.

    Firstly, we prove that E=e,e=(e1,e2) is the only positive solution of system (3.1). Assume that E=e and E=k are two positive solutions of system (3.1), both nonzero. If ek, then eiki for some i (i = 1, 2). Assume without loss of generality that e1>k1, and moreover that e1/k1ei/ki for all i (i = 1, 2). Since e and k are positive solutions of system (3.1), we substitute them into (3.1). It is easy to obtain

    M1(A1n1e1)2j=1ξ1jejn1e1=M1(A1n1k1)2j=1ξ1jkjn1k1=0,

    so

    M1(A1n1e1)2j=1ξ1jejk1e1n1k1=M1(A1n1k1)2j=1ξ1jkjn1k1=0,
    M1(A1n1e1)2j=1ξ1jejk1e1=M1(A1n1k1)2j=1ξ1jkj.

    But (ei/e1)k1ki and M1(A1n1e1)<M1(A1n1k1); thus from the above equalities we get

    M1(A1n1e1)2j=1ξ1jejk1e1M1(A1n1e1)2j=1ξ1jkj<M1(A1n1k1)2j=1ξ1jkj.

    This is a contradiction, so there is only one positive solution Ei=e of system (3.1). So when R0>1, system (2.2) only exists a positive equilibrium P.

    In this section, we will show the global asymptotic stability of endemic equilibrium P of system (2.2) in the interior of the feasible region X.

    Theorem 3.4. Suppose that matrix [βij]1i,j2 is irreducible. Then the endemic equilibrium P of system (2.2) is globally asymptotically stable in the region X when R0>1.

    Proof. Let Li1=SiSiSilnSiSi+ViViVilnViVi+EiEiEilnEiEi, Li2=IiIiIilnIiIi and L3=WWWlnWW. For i=1,2, differentiating and using the equilibrium equations give

    dLi1dt=(1SiSi)Si+(1ViVi)Vi+(1EiEi)Ei=(1SiSi)(Ai(di+γi)Si+λiVi2j=1βijSiEjβiSiW)+(1ViVi)(γiSi(λi+di)Vi)+(1EiEi)(2j=1βijSiEj+βiSiW(di+ci)Ei)=(1SiSi)((di+γi)(SiSi)+λi(ViVi)2j=1βij(SiEjSiEj))(1SiSi)βi(SiWSiW)+γiSi(1ViVi)(SiSiViVi)+(1EiEi)(2j=1βij(SiEjSiEjEiEi)+βi(SiWSiWEiEi))=diSi(2SiSiSiSi)+λiVi(2SiViSiViSiViSiVi)+diVi(3SiSiViViSiViSiVi)+2j=1βijSiEj((1SiSi)(SiEjSiEj1)+(1EiEi)(SiEjSiEjEiEi))+βiSiW((1SiSi)(SiWSiW1)+(1EiEi)(SiWSiWEiEi))2j=1βijSiEj(2SiSiEiEi+EjEjSiEjEiSiEjEi)+βiSiW(2SiSiEiEi+WWSiWEiSiWEi).

    Using the inequality 1alna,a>0, one can obtain that

    2SiSiEiEi+EjEjSiEjEiSiEjEiEjEjEiEilnSiSilnSiEjEiSiEjEi=EjEjlnEjEj+lnEiEiEiEi,2SiSiEiEi+WWSiWEiSiWEiWWEiEilnSiSilnSiWEiSiWEi=WWlnWW+lnEiEiEiEi.

    Hence, we have

    dLi1dt2j=1βijSiEj(2SiSiEiEi+EjEjSiEjEiSiEjEi)+βiSiW(2SiSiEiEi+WWSiWEiSiWEi)2j=1βijSiEj(EjEjlnEjEj+lnEiEiEiEi)+βiSiW(WWlnWW+lnEiEiEiEi).

    Similarly, we can obtain

    dLi2dt=(1IiIi)Ii=(1IiIi)(ciEi(di+αi)Ii)=(1IiIi)(ciEiciEiIiIi)=ciEi(1+EiEiIiIiEiIiEiIi)ciEi(EiEilnEiEi+lnIiIiIiIi).
    dL3dt=(1WW)W=(1WW)(2j=1(kiEi+miIi)δW)=(1WW)(2j=1(kiEi+miIi)2j=1(kiEi+miIi)WW)2i=1kiEi(EiEilnEiEi+lnWWWW)+2i=1miIi(IiIilnIiIi+lnWWWW).

    Define the Lyapunov function

    L=2i=1υi(ai1Li1+ai2Li2+ai3L3).

    It follows that

    dLdt=2i=1υi(ai1Li1+ai2Li2+ai3L3)2i=1υi(ai12j=1βijSiEj(EjEjlnEjEj+lnEiEiEiEi)+ai1βiSiW(WWlnWW+lnEiEiEiEi)+ai2ciEi(EiEilnEiEi+lnIiIiIiIi)+ai32i=1kiEi(EiEilnEiEi+lnWWWW)+ai32i=1miIi(IiIilnIiIi+lnWWWW)).

    Considering the following equations

    {(ai1βiSiWai32i=1(kiEi+miIi))(WWlnWW)=0,(ai32i=1miIiai2ciEi)(IiIilnIiIi)=0.

    We have

    ai2=2i=1miIiciEiai3,ai3=βiSiW2i=1(kiEi+miIi)ai1.

    and

    (ai1βiSiWai2ciEiai32i=1kiEi)(lnEiEiEiEi)=0

    Let ai2=1 and take the equation ai2 and ai3 into the equation dLdt, we can obtain

    dLdt=2i=1υi(Li1+βiSiW2i=1(kiEi+miIi)(2i=1miIiciEiLi2+L3))2i=1υi(2j=1βijSiEj(EjEjlnEjEj+lnEiEiEiEi))=2i,j=1υiβijSiEj(EjEjlnEjEj+lnEiEiEiEi)

    Due to matrix [βij]1i,j2 is irreducible, hence we can calculate υ1=β21S2E1,υ2=β12S1E2 such that

    2i,j=1υiβijSiEj(EjEjlnEjEj+lnEiEiEiEi)=0.

    The equality L=0 holds only for Si=Si,Ei=Ei,Ii=Ii,i=1,2 and W=W. Hence, one can obtain that the largest invariant subset where L=0 is the singleton P using the same argument as in [24]. By LaSalle's Invariance Principle [25], P is globally asymptotically stable in the region X when R0>1.

    Remark 3.1. In this model, the host populations are divided into 2 homogeneous groups. If the host populations have n groups, we can extend our Lyapunov function into the following equation:

    L=ni=1υi(Li1+βiSiWni=1(kiEi+miIi)(ni=1miIiciEiLi2+L3))

    Furthermore we can obtain that

    dLdt=ni=1υi(Li1+βiSiWni=1(kiEi+miIi)(ni=1miIiciEiLi2+L3))ni,j=1υiβijSiEj(EjEjlnEjEj+lnEiEiEiEi)

    Hence, if the matrix [βij]1i,jn is irreducible, and according to the methods and conclusions in [24,26,27], there exist constants υi>0,i=1,2,...,n such that

    ni,j=1υiβijSiEj(EjEjlnEjEj+lnEiEiEiEi)=0.

    In an epidemic model, the basic reproduction number R0 is calculated and shown to be a threshold for the dynamics of the disease. Taking parameter values δ=3.6,A1=1976000,d1=0.6, λ1=0.4,A2=1680000,d2=0.4, λ2=0.4,α2=12,α1=12, β1=1.0×108,β11=1.8×107, β2=1.0×108,β22=2.1×107, k1=15,k2=15, γ1=0.316×0.82,γ2=0.316×0.82, c1=0.15,c2=0.15, β12=β21=1.35×107 in paper [3], we run numerical simulations with system (2.2) for R0>1 (see Figure 2) and R0<1 (see Figure 3) to demonstrate the conclusions in Theorem 3.4 and Theorem 3.1.

    Figure 2.  Numerical simulations for R0=1.9789>1 with different initial values. (a) The infectious cases with group 1. (b) The infectious cases with group 2.
    Figure 3.  Numerical simulations for R0=0.8330<1 with different initial values, where γ1=1×0.82,γ2=0.316×0.82,c1=0.3,c2=0.3,β12=β21=0. (a) The infectious cases with group 1. (b) The infectious cases with group 2.

    In order to evaluate the influence for infectious individuals over time with the key parameters (such as the efficient vaccination rate γ1,γ2, the seropositive detection rate c1,c2, and the transmission rate β1,β11,β2,β22,β12,β21). We explored these parameter space by performing an uncertainty analysis using a Latin hypercube sampling (LHS) method and sensitivity analysis using partial rank correlation coefficients (PRCCs) with 1000 samples [28]. In the absence of available data on the distribution functions, we chose a normal distribution for all selected input parameters with the same values in paper [3], and tested for significant PRCCs for these parameters of system (2.2). PRCC indexes can be calculated for multiple time points and plotted versus time, and this can allow us to assess whether significance of one parameter occur over an entire time interval during the progression of the model dynamics.

    Figure 4 show the plots of 1000 runs output and PRCCs plotted for selected parameters with respect to the number of infected individuals in group 1 and 2 for system (2.2). Figure 4 (b) and (d) show that the effects of parameters γ1,γ2,c1,c2,β1,β11, β2,β22,β12,β21 change with respect to I1 and I2 over time. In the early time, these selected parameters with PRCCS have obvious change, and finally they remain constant. In Figure 4 (b), the efficient vaccination rate γ1,γ2 and the seropositive detection rate of group 2 c2 are negatively correlated with PRCCs for I1, and the other parameters are positively correlated with PRCCs for I1. But In Figure 4 (d), the seropositive detection rate of group 2 c2 is positively correlated with PRCCs and the seropositive detection rate of group 1 c1 is negatively correlated with PRCCs, other parameters have the same correlation with PRCCs for I1. From Figure 4, we can see the efficient vaccination rate γ1,γ2 have the strong negatively correlated PRCCs (black solid and dotted lines) for I1 and I2, and the seropositive detection rate has the strong positively correlated with PRCCs for infected individuals. Hence, one can conclude that the vaccination and the seropositive detection of infected individuals are the effective control measures.

    Figure 4.  Sensitivity analysis. (a) and (c) Plots of output (1000 runs) of system (2.2) for I1 and I2. (b) and (d) PRCCs of system (2.2) for I1 and I2 with parameters γ1,γ2,c1,c2,β1,β11,β2,β22, β12,β21.

    To find better control strategies for brucellosis infection, we perform some sensitivity analysis of the basic reproduction number R0 in terms of the efficient vaccination rate (γ1,γ2) and the seropositive detection rate (c1,c2). We show the combined influence of parameters on R0 in Figure 5. Figure 5(a) depicts the influence of sheep efficient vaccination rate γ1,γ2 on R0. Though vaccinating susceptible sheep is an effective measure to decrease R0, R0 cannot become less than one even if the vaccination rate of all sheep is 100% (which is the efficient vaccination rate γ1=0.82,γ2=0.82 in Figure 5(a), under this circumstances R0=1.3207). Figure 5(b) indicates the influence of seropositive detection rate c1,c2 on R0, which shows to increase seropositive detection rate of recessive infected sheep can make R0 less than one, which means under the current control measures, increase seropositive detection rate of recessive infected sheep can control the brucellosis. Hence, we can conclude that combining the strategy of vaccination and detection is more effective than vaccination and detection alone to control brucellosis.

    Figure 5.  The combined influence of parameters on R0. (a) R0 in terms of γ1 and γ2. (b) R0 in terms of c1 and c2. Other parameters are the same values in paper [3].

    In this paper, in order to show the uniqueness and global stability of the endemic equilibrium for brucellosis transmission model with common environmental contamination, the multi-group model in paper [3] is chosen as our research objectives. Firstly, we show the basic reproduction number R0 of the model (2.2). Then, we obtain the uniqueness of positive endemic equilibrium through using proof by contradiction when R0>1. Finally, the proof of global asymptotical stability of the endemic equilibrium when R0>1 is shown by using Lyapunov function. Especially, we give the specific coefficients of global Lyapunov function, and show the calculation method of these specific coefficients. Numerical analysis also show that the global asymptotic behavior of system (2.2) is completely determined by the size of the basic reproduction number R0, that is, the disease free equilibrium is globally asymptotically stable if R0<1 while an endemic equilibrium exists uniquely and is globally stable if R0>1. With the uncertainty and sensitivity analysis of infected individuals for selected parameters γ1,γ2,c1,c2,β1,β11,β2,β22, β12,β21 using LHS/PRCC method, one can conclude that the efficient vaccination rate γ1,γ2 have the strong negatively correlated PRCCs (black solid and dotted lines in Figure 4), and the seropositive detection rate has the strong positively correlated with PRCCs for infected individuals. By some sensitivity analysis of the basic reproduction number R0 on parameters, we find that vaccination rate of sheep and seropositive detection rate of recessive infected sheep are very important factor for brucellosis.

    The project is funded by the National Natural Science Foundation of China under Grants (11801398, 11671241, 11601292) and Natural Science Foundation of Shan'Xi Province Grant No. 201801D221024.

    All authors declare no conflicts of interest in this paper.



    [1] WHO (2018) Cancer, Fact sheets 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.
    [2] Ervik M, Lam F, Ferlay J, et al. (2016) Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: http://gco.iarc.fr/today.
    [3] WHO. Global status report on noncommunicable diseases 2010. Available from: https://www.who.int/nmh/publications/ncd_report_full_en.pdf.
    [4] Alharthi H (2018) Healthcare predictive analytics: An overview with a focus on Saudi Arabia. J Infect Public Health 11: 749–756. doi: 10.1016/j.jiph.2018.02.005
    [5] WHO, International Agency for Research in Cancer (IARC). Saudi Arabia. Source: Globocan 2018. Available from: https://gco.iarc.fr/today/data/factsheets/populations/682-saudi-arabia-fact-sheets.pdf.
    [6] Bassam AA, Rakan FA, Ahmed AA, et al. (2017) Breast cancer in Saudi Arabia and its possible risk factors. J Cancer Policy 12: 83–89. doi: 10.1016/j.jcpo.2017.03.004
    [7] Agide FD, Sadeghi R, Garmaroudi G, et al. (2018) A systematic review of health promotion interventions to increase breast cancer screening uptake: from the last 12 years. Eur J Public Health 28: 1149–1155. doi: 10.1093/eurpub/ckx231
    [8] Aldiab A, Al Khayal KA, Al Obaid OA, et al. (2017) Clinicopathological Features and Predictive Factors for Colorectal Cancer Outcome in the Kingdom of Saudi Arabia. Oncology 92: 75–86. doi: 10.1159/000450857
    [9] Alsanea N, Almadi MA, Abduljabbar AS, et al. (2015) National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence. Ann Saudi Med 35: 189–195. doi: 10.5144/0256-4947.2015.189
    [10] Zubaidi AM, AlSubaie NM, AlHumaid AA, et al. (2015) Public awareness of colorectal cancer in Saudi Arabia: A survey of 1070 participants in Riyadh. Saudi J Gastroenterol 21: 78–83. doi: 10.4103/1319-3767.153819
    [11] Alqahtani M, Edwards C, Buzzacott N, et al. (2018) Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing. Fam Cancer 17: 197–203. doi: 10.1007/s10689-017-0015-9
    [12] Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68: 7–30. doi: 10.3322/caac.21442
    [13] Taha MS, Almsned FM, Hassen MA, et al. (2018) Demographic and histopathological patterns of neuro-epithelial brain tumors in Eastern Province of Saudi Arabia. Neurosciences (Riyadh, Saudi Arabia) 23: 18–22. doi: 10.17712/nsj.2018.1.20160543
    [14] Aljuhani SH, Bamaroof SA, Alghamdi TH, et al. (2018) Public awareness of central nervous system tumors in the Kingdom of Saudi Arabia. Neurosciences (Riyadh, Saudi Arabia) 23: 227–237. doi: 10.17712/nsj.2018.3.20180055
    [15] Azim HA, Abdel-Malek R, Kassem L (2018) Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology. Clin Breast Cancer 18: e187–e195. doi: 10.1016/j.clbc.2017.08.004
    [16] Rauf MS, Akhtar S, Maghfoor I (2015) Changing trends of adult lymphoma in the Kingdom of Saudi Arabia - comparison of data sources. Asian Pac J Cancer Prev 16: 2069–2072. doi: 10.7314/APJCP.2015.16.5.2069
    [17] Ahmed MI, Ahmed MS, Nizamani WM, et al. (2018) Beyond PET/CT in lymphoma: Does PET/CT has similar diagnostic accuracy in recurrent lymphoma cases in TB-endemic countries. Pak J Radiol 28: 17–23.
    [18] Nagi AH, Minawy LA, Naseem N, et al. (2010) A study of the morphological patterns of extranodal non-Hodgkin lymphoma in Pakistani and Saudi populations. Biomedica 26: 118–123.
    [19] Al Diab AR, Aleem A, Qayum A, et al. (2011) Clinico-pathological pattern of extranodal non-Hodgkin's lymphoma in Saudi Arabia. Asian Pac J Cancer Prev 12: 3277–3282.
    [20] Saudi Cancer Registry Annual Report (2014) Riyadh: Ministry of Health. Available from: https://nhic.gov.sa/eServices/Documents/2014.pdf.
    [21] Shamoon RP, Ali MD, Shabila NP (2018) Overview and outcome of Hodgkin's Lymphoma: Experience of a single developing country's oncology centre. Plos One 13.
    [22] Toorani ZA, Sridhar S, Roque W (2018) A rare concurrence of Hofgkin's lymphoma, Sickle cell disease and Diabetes mellitus. Bahrain Med Bull 40: 118–120. doi: 10.12816/0047565
    [23] Medina-Rico M, Ramos HL, Lobo M, et al. (2018 Epidemiology of renal cancer in developing countries: Review of the literature. Can Urol Assoc 12: 154–162.
    [24] Alkhateeb SS, Alothman AS, Addar AM, et al. (2018) Kidney cancer in Saudi Arabia. Saudi Med J 39: 459–563. doi: 10.15537/smj.2018.5.22641
    [25] Mahasin SZ, Aloudah N, Al-Surimi K, et al. (2018) Epidemiology profile of renal cell carcinoma: A 10-years patients' experience at king Abdulaziz Medical City, National Huard Health Affairs, Saudi Arabia. Urol Ann 10: 59–64. doi: 10.4103/UA.UA_102_17
    [26] Bafaraj S, Awad I, Jastaniah S, et al. (2018) Screening for thyroid diseases among students of applied medical sciences at King Abdulaziz University, Saudi Arabia. Saudi Med J 39: 311–314. doi: 10.15537/smj.2018.3.22137
    [27] Saeed MI, Hassan AA, Butt ME, et al. (2018) Pattern of thyroid lesions in western region of Saudi Arabia: A retrospective analysis and literature review. J Clin Med Res 10: 106–116. doi: 10.14740/jocmr3202w
    [28] PRISMA (2018) Statement on transparent reporting of systematic reviews and meta-analysis. Available from: http://www.prisma-statement.org/.
    [29] GLOBECAN 2012. International Agency for Research on Cancer [online database]. Available from: http://www-dep.iarc.fr/.
    [30] WHO. Breast cancer burden 2017. Available from: http://www.who.int/cancer/detection/breastcancer/en/index1.html.
    [31] Mir R, Javid J, Al Balawi A, et al. (2018) A germline mutation in BRCA1 3'UTR variant predicts susceptibility to breast cancer in a Saudi Arabian population. Asian Pac J Cancer Prev 19: 859–866.
    [32] Al Balawi IA, Mir R, Abu-Duhier FM (2018) Potential impact of vascular endothelial growth factor gene variation ( − 2578C> A) on breast cancer susceptibility in Saudi Arabia: a case-control study. Asian Pac J Cancer Prev 19: 1135–1143.
    [33] Alhuquail AJ, Alzahrani A, Almubarak H, et al. (2018) High prevalence of deliterous BRCA 1 and BRCA 2 germline mutations in arab breast and ovarian cancer patients. Breast Cancer Res Treat.
    [34] Rahman S, Zayed H (2018) Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRAC1/2 genes. Gene.
    [35] Abulkhair O, Saadeddin A, Makran O, et al. (2015) Vitamin D levels and breast cancer characteristics: Findings in patients from Saudi Arabia. J Steroid Biochem Mol Biol.
    [36] Ifediora CO (2019) Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools. BMC Public Health 19: 503. doi: 10.1186/s12889-019-6890-2
    [37] Alshatwi AA, Hasan TN, Shafi G, et al. (2011) A single nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol 26: 438–443. doi: 10.1111/j.1472-8206.2011.00939.x
    [38] Al-Qasem A, Toulimat M, Tulbah A, et al. (2012) The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. Oncol Lett 3: 875–878.
    [39] Alshatwi AA, Shafi G, Hasan TN, et al. (2012) Differential Expression Profile and Genetic Variants of MicroRNAs Sequences in Breast Cancer Patients. Plos One 7: e30049. doi: 10.1371/journal.pone.0030049
    [40] Alghamdi IG, Hussain II, Alghamdi MS, et al. (2013) The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008. Breast Cancer: Targets Ther 5: 103–109. doi: 10.2147/BCTT.S50750
    [41] Alanazi M, Pathan AAK, Arifeen Z, et al. (2013) Association between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi population. Plos One 8: e85541. doi: 10.1371/journal.pone.0085541
    [42] Yousef FM, Jacobs ET, Kang PT, et al. (2013) Vitamin D status and breast cancer in Saudi Arabian women: case-control study. Am J Clin Nutr 98: 105–110. doi: 10.3945/ajcn.112.054445
    [43] Al-Mutairi FM, Alanazi M, Shalaby M, et al. (2013) Association of XRCC1 gene polymorphisms with breast cancer susceptibility in Saudi patients. Asian Pac J Cancer Prev 14: 3809–3813. doi: 10.7314/APJCP.2013.14.6.3809
    [44] Alokail MS, Al-Daghri N, Abdulkareem A, et al. (2013) Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/ or a pre existing metabolic syndrome-related neoplasia risk? BMC Cancer 13: 54. doi: 10.1186/1471-2407-13-54
    [45] Hasan TN, Shafi G, Syed NA, et al. (2013) Lack of association of BRCA1 and BRCA2 variants with breast cancer in an ethnic population of Saudi Arabia, an emerging high-risk area. Asian Pac J Cancer Prev 14: 5671–5674. doi: 10.7314/APJCP.2013.14.10.5671
    [46] Elkum N, Al-Tweigeri T, Ajarim D, et al. (2014) Obesity is a significant risk factor for breast cancer. BMC Cancer 14: 788. doi: 10.1186/1471-2407-14-788
    [47] Benard F, Barkun AN, Martel M, et al. (2018) Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarising the current global recommendations. World J Gasteroenterol 24: 124–138. doi: 10.3748/wjg.v24.i1.124
    [48] Williams CE, Williams EA, Corfe BM (2018) Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know? Eur J Clin Nutr 72: 1358–1363. doi: 10.1038/s41430-017-0064-z
    [49] Al-Harithy RN, Al-Ghafari AB (2010) Risistin in human colon cancer. Saudi Med J 31: 495–500.
    [50] Al-Harithy RN, Al-Zahrani MH (2012) The adinponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett 3: 176–180. doi: 10.3892/ol.2011.443
    [51] Al-Harithy RN, Al-Ghazzawi (2011) Polymorphisms of the deoxyribonucleic acid (DNA) repair gene XRCC1 and risk of colon cancer in Saudi Arabia. Int J Med Med Sci 3: 281–288.
    [52] Alharithy RN (2014) Polymorphisms in RETN gene and susceptibility to colon cancer in Saudi patients. Ann Saudi Med 34: 334–339. doi: 10.5144/0256-4947.2014.334
    [53] Alghafari AB, Balamash KS, Doghaither HA, et al. (2019) "Relationship between Serum Vitamin D and Calcium Levels and Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer". BioMed Res Int.
    [54] Albasri A, El-Siddig A, Hussainy A, et al. (2014a) Histopathologic characterization of prostrate diseases in Madinah, Saudi Arabia. Asian Pac J Cancer Prev 15: 4175–4179.
    [55] Ross-Adams H, Lamb AD, Dunning MJ, et al. (2015) Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. EBioMedicine 2: 1133–1144. doi: 10.1016/j.ebiom.2015.07.017
    [56] Travis RC, Appleby PN, Martin RM, et al. (2016) A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res 76: 2288–2300. doi: 10.1158/0008-5472.CAN-15-1551
    [57] Al-Abdin OZ, Rabah DM, Badr G, et al. (2013) Differences in prostrate cancer detection between Canadian and Saudi populations. Braz J Med Biol Res 46: 539–545. doi: 10.1590/1414-431X20132757
    [58] Alghamdi IG, Hussain II, Alghamdi MS, et al. (2014) The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer registry 2001–2008. Hematol/Oncol Stem Cell Ther 7: 18–26. doi: 10.1016/j.hemonc.2013.10.001
    [59] Shafi RG, Al-Mansour MM, Kanfar SS, et al. (2017) Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia. Oncol Res Treat 40: 288–292. doi: 10.1159/000460819
    [60] Dalia S, Chavez J, Castillo JJ, et al. (2013) Hepatitis B infection increases the risk of non-Hodkin lymphoma: A meta-analysis of observational studies. Leuk Res 37: 1107–1115. doi: 10.1016/j.leukres.2013.06.007
    [61] Alkhateeb SS, Alkhateeb JM, Ahrashidi EA (2015) Increasing trends in kidney cancer over the last 2 decades in Saudi Arabia. Saudi Med J 36: 698–703. doi: 10.15537/smj.2015.6.10841
    [62] Hajeer MH, Awad HA, Abdullah NI, et al. (2018) The rising trend in papillary thyroid carcinoma. Saudi Med J 39: 147–153. doi: 10.15537/smj.2018.2.21211
    [63] Zhang Y, Chen Y, Huang H, et al. (2015) Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study. Eur J Cancer Prev 24: 439–446. doi: 10.1097/CEJ.0000000000000169
    [64] Hussain F, Iqbal S, Mehmood A, et al. (2013) Incidence of thyroid cancer in kingdom of Saudi Arabia, 2000–2010. Hematol/Oncol Stem Cell Ther 6: 58–64. doi: 10.1016/j.hemonc.2013.05.004
    [65] Albasri A, Sawaf Z, Hussainy AS, et al. (2014c) Histopathological patterns of thyroid disease in Al-Madinah region of Saudi Arabia. Asian Pac J Cancer Prev 15: 5565–5570.
    [66] Abdo N, Khader YS, Abdelrahman M, et al. (2016) Respiratory health outcomes and air pollution in the Eastern Mediterranean Region: a systematic review. Rev Environ Health 31: 259–280. doi: 10.1515/reveh-2015-0076
    [67] Al-Hazzaa HM (2018) Physical inactivity in Saudi Arabia revisited: A systematic review of inactivity prevalence and perceived barriers to active living. Int J Health Sci (Qassim) 12: 50–64.
    [68] Al-Musa HM, Awadalla NJ, Mahfouz AA (2019) Male Partners' Knowledge, Attitudes, and Perception of Women's Breast Cancer in Abha, Southwestern Saudi Arabia. Int J Environ Res Public Health 16: 3089. doi: 10.3390/ijerph16173089
    [69] Aldohaian AI, Alshammari SA, Arafah DM (2019) Using the health belief model to assess beliefs and behaviors regarding cervical cancer screening among Saudi women: a cross-sectional observational study. BMC Womens Health 19: 6. doi: 10.1186/s12905-018-0701-2
  • This article has been cited by:

    1. Gui-Quan Sun, Ming-Tao Li, Juan Zhang, Wei Zhang, Xin Pei, Zhen Jin, Transmission dynamics of brucellosis: Mathematical modelling and applications in China, 2020, 18, 20010370, 3843, 10.1016/j.csbj.2020.11.014
    2. E.R. Pinto, E.G. Nepomuceno, A.S.L.O. Campanharo, Individual-Based Modelling of Animal Brucellosis Spread with the Use of Complex Networks, 2022, 2653-6226, 120, 10.53941/ijndi0101011
    3. Guoxi Zeng, Xamxinur Abdurahman, Stationary distribution and extinction of a stochastic cattle brucellosis model, 2022, 15, 25900374, 100320, 10.1016/j.rinam.2022.100320
    4. Xin-Ming Yang, Yong-Li Jia, Ying Zhang, Pei-Nan Zhang, Yao Yao, Yan-Lin Yin, Ye Tian, Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin in the Treatment of Brucellosis Spondylitis, 2021, Volume 15, 1177-8881, 4733, 10.2147/DDDT.S341242
    5. Xia Ma, Mingtao Li, Juan Zhang, Xiaofeng Luo, Gui-Quan Sun, Interactions of periodic birth and shearing induce outbreak of Brucellosis in Inner Mongolia, 2022, 15, 1793-5245, 10.1142/S1793524522500437
    6. Xia Ma, Gui-Quan Sun, Zheng-Hua Wang, Yuan-Ming Chu, Zhen Jin, Bai-Lian Li, Transmission dynamics of brucellosis in Jilin province, China: Effects of different control measures, 2022, 114, 10075704, 106702, 10.1016/j.cnsns.2022.106702
    7. Sumit Kumar, Sandeep Sharma, Atul Kashyap, Nitu Kumari, Ravi P. Agarwal, Modelling the effect of environmental pollution on Zika outbreak: A case study of Brazil, 2023, 0, 1937-1632, 0, 10.3934/dcdss.2023048
    8. 雨欣 王, Modeling of Brucellosis Dynamics and Its Control Measures Based on Price Factors, 2023, 12, 2324-7991, 2502, 10.12677/AAM.2023.125252
    9. Xia Ma, Gui-Quan Sun, Global dynamics of a periodic brucellosis model with time delay and environmental factors, 2024, 130, 0307904X, 288, 10.1016/j.apm.2024.03.002
    10. Lei-Shi Wang, Ming-Tao Li, Xin Pei, Juan Zhang, Gui-Quan Sun, Zhen Jin, Cost assessment of optimal control strategy for brucellosis dynamic model based on economic factors, 2023, 124, 10075704, 107310, 10.1016/j.cnsns.2023.107310
    11. Wei Gong, Peng Sun, Changsheng Zhai, Jing Yuan, Yaogeng Chen, Qun Chen, Yu Zhao, Accessibility of the three-year comprehensive prevention and control of brucellosis in Ningxia: a mathematical modeling study, 2023, 23, 1471-2334, 10.1186/s12879-023-08270-4
    12. Bei Sun, Daozhou Gao, Xueying Wang, Yijun Lou, Infection-induced host extinction: Deterministic and stochastic models for environmentally transmitted pathogens, 2025, 00255564, 109374, 10.1016/j.mbs.2025.109374
    13. Bashir Al-Hdaibat, Muhammad Altaf Khan, Irfan Ahmad, Ebraheem Alzahrani, Ali Akgul, Modeling and analyzing the dynamics of brucellosis disease with vaccination in the fractional derivative under real cases, 2025, 1598-5865, 10.1007/s12190-025-02435-x
    14. Caihong Song, Zigen Song, Global dynamics and optimal control strategies for the brucellosis model with environmental saturation infection: An assessment of severely affected provinces in China, 2025, 03784754, 10.1016/j.matcom.2025.04.008
    15. 姝 杜, Research on Optimal Brucellosis Control Strategy in Xinjiang Based on Dynamic Price Factors, 2025, 14, 2324-7991, 843, 10.12677/aam.2025.144211
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(14003) PDF downloads(571) Cited by(69)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog